Compare LVS & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LVS | MDLN |
|---|---|---|
| Founded | 1988 | 1966 |
| Country | United States | United States |
| Employees | N/A | 45000 |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.5B | 34.1B |
| IPO Year | 2004 | N/A |
| Metric | LVS | MDLN |
|---|---|---|
| Price | $54.18 | $42.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 23 |
| Target Price | ★ $68.86 | $50.48 |
| AVG Volume (30 Days) | 3.1M | ★ 5.5M |
| Earning Date | 04-22-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | ★ 19.90 | N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | ★ $13,017,000,000.00 | N/A |
| Revenue This Year | $7.22 | $10.88 |
| Revenue Next Year | $4.50 | $7.69 |
| P/E Ratio | ★ $23.09 | $658.75 |
| Revenue Growth | ★ 15.22 | N/A |
| 52 Week Low | $30.52 | $38.50 |
| 52 Week High | $70.45 | $50.88 |
| Indicator | LVS | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 45.82 |
| Support Level | $51.72 | $40.90 |
| Resistance Level | $55.88 | $44.11 |
| Average True Range (ATR) | 1.39 | 1.52 |
| MACD | 0.28 | 0.23 |
| Stochastic Oscillator | 67.80 | 39.55 |
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.